Support Line: 0300 373 8500
The WM-VOICE study is looking for UK patients to share their views anonymously as a part of first-of-its-kind study, looking at the treatment preferences of WM patients.
Waldenstrom’s macroglobulinaemia (WM) is a rare type of blood cancer. It has its own distinct characteristics that require specialised treatment and care. Our vision is that people affected by WM live longer, good quality lives supported every step of the way by WMUK.
Working hard to provide up to date information and personal support for people affected by Waldenstrom’s macroglobulinaemia (WM), a rare form of blood cancer.
We aim to improve understanding and access to treatment and care to ensure everyone with WM can live longer, better quality lives.
We do this through the dedication and support of donors and fundraisers, without whom the charity and its resources would not exist. Help us to continue helping the WM community here.
WMUK understand the challenges and uncertainties that come with a Waldenstrom’s macroglobulinaemia blood cancer diagnosis. That’s why we offer a range of support services tailored to meet the diverse needs of patients and their families.
Information and Resources: Explore a wealth of information and resources on Waldenstrom’s macroglobulinaemia, covering treatment options, specialist centres, and invaluable guidance for patients, caregivers, and those newly diagnosed.
Community and Support: Join our nurturing community through our support groups and online Facebook groups. Reach out to our dedicated helpline team for personalised support and guidance.
Updates and Events: Stay updated on our latest news, campaigns, and events, including regular online meet-ups, expert webinars, and the annual patient forum.
Find nearby support groups for Waldenstrom’s macroglobulinaemia, or contact our support line.
WMUK telephone support line offers support, advice, and signposting, Monday to Thursday from 9 AM to 5 PM
Find nearby support groups for Waldenstrom’s macroglobulinaemia, or contact our support line.
Explore our comprehensive guide to receiving treatment for Waldenstrom’s macroglobulinaemia
Your starting to point to find out all about the rare blood cancer, Waldenstrom’s macroglobulinaemia (WM).
Professor Diana Greenfield, Consultant Nurse in Late Effects (of cancer treatment) at Sheffield Teaching Hospital, will be joined by a WMer with lived experience of the late effects of treatment. They’ll discuss what late effects are, and how self-empowerment can help to live well with WM.
Register here
Join our Support Line Nurse, Beth, for an informal drop-in session. This is a chance to ask questions and listen to stories from others in the WM community. No need to register, just join anytime during the hour long session using the button below.
Join Coffee and Chat We’ll be joined by Dr Jamail Kothari and WM patient Harriet Scorer to talk all things clinical trials.
Register here Join our Support Line Nurse, Beth, for a special Coffee and Chat session focussed on peripheral neuropathy. This condition affects many people with WM, and the informal drop-in session will be a great way to ask any questions or get support from others in a similar situation.
Join here Join our Support Line Nurse, Beth, for an informal drop-in session. This is a chance to ask questions and listen to stories from others in the WM community. No need to register, just join anytime during the hour long session using the button below.
Join herePhone support, regional groups, & online forums supporting people affected by WM
Answers to some of the most common questions for those newly diagnosed with WM
Symptoms vary from person to person. Here we describe some of the most common symptoms.
Everything you need to know about the different treatments available for WM
An introduction to diet, exercise, symptom management, mental health support, and work-life balance.
A easy to understand explanation of Waldenstrom’s macroglobulinaemia
Explore & download our guides, watch webinars, find factsheets and more in our library
Find out what happens if you’ve been in remission, and have a relapse.
The Registry collates information for medical professionals about this rare cancer
